OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-AG88         View EO 12866 Meetings	Received Date: 06/18/2013
Title: Revision of Postmarketing Reporting Requirements Discontinuance or Interruption in Supply of Certain Products (Drug Shortages)
Agency/Subagency: HHS / FDA	Stage: Proposed Rule
Concluded Action: Consistent with Change	Concluded Date: 10/01/2013
Legal Deadline: Statutory	Economically Significant: Yes
Publication Date: 11/04/2013	Unfunded Mandates: No
Major: Yes	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Undetermined	Small Entities Affected:
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected